share_log

Crispr Therapeutics Price Target Announced at $160.00/Share by JMP Securities

Dow Jones Newswires ·  Mar 4, 2021 21:16

DJ Crispr Therapeutics Initiated at Outperform by JMP Securities

Ratings actions from Benzinga: https://www.benzinga.com/stock/CRSP/ratings

(END) Dow Jones Newswires

March 04, 2021 08:16 ET (13:16 GMT)

DJ Crispr Therapeutics Price Target Announced at $160.00/Share by JMP Securities

Ratings actions from Benzinga: https://www.benzinga.com/stock/CRSP/ratings

(END) Dow Jones Newswires

March 04, 2021 08:16 ET (13:16 GMT)

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment